Remdesivir receives FDA approval; first FDA-approved COVID-19 treatment in US
BATON ROUGE - Remdesivir has received The U.S. Food and Drug Administration's approval to treat hospitalized COVID-19 patients, becoming the first FDA-approved treatment for the virus in the United States as of Thursday, Oct. 22.
Gilead Sciences' antiviral drug began being used to treat the coronavirus in May as the FDA approved it for emergency use, allowing hospitals and doctors to use the drug on hospitalized patients although it had not been formally approved.
The antiviral drug is said to stop the virus from replicating inside of the body and significantly decreases the time patients spend in the hospital, according to researchers. The drug was used to treat President Donald Trump earlier this month.
Dr. Anthony Fauci, the nation’s leading infectious disease expert, spoke highly of the treatment back in April.
"The data shows that Remdesivir has a clear-cut, significant positive effect in diminishing the time to recovery. This is really important," Dr. Fauci said.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Volunteer group works to clean up Capitol Lake and keep wildlife safe...
Local businesses kick off the holiday shopping season with Small Business Saturday
Possible tornado sweeps through St. Charles, Jefferson Parishes; nearly 5,500 without power...
Car submerged in canal after driver veered off I-12 near Essen Lane;...
Two hurt in apparent Black Friday gun battle between two vehicles on...
Southeastern hosting Idaho in first round of FCS Playoffs Saturday
Fans' Choice Award Winner: U-High's Keylan Moses
Southeastern running back Derrick Graham has a deep passion for rodeo
Southeastern to face Idaho in first round of FCS Playoffs
The Black and Gold Report: New Orleans Saints vs Los Angeles Rams